Product Information
CLOBETASOL 0.05% OINTMENT is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1146 per GM under NDC 59651073260. Its NADAC has been published 92 times since Jan 1, 2025.
FDA first approved this application on Aug 12, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/g
Manufacturer
Aurobindo Pharma LimitedNDC
59651073260
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
CLOBETASOL PROPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA075057FDA Approved
8/12/1998
TE Code
AB
On Market Since
9/28/2023
Pharmacological Classes
Price Statistics
The NADAC for CLOBETASOL 0.05% OINTMENT has been published 92 times since Jan 1, 2025, and over the history we have for it it has declined 3.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1146 per GM |
|---|---|
| All-time high | $0.1627 (Jul 16, 2025) |
| All-time low | $0.1101 (Mar 18, 2026) |
| 52-week high | $0.1312 |
| 52-week low | $0.1101 |
| Median price | $0.1222 |
| Average price | $0.1291 |
| Largest weekly change | +15.9% (Feb 19, 2025) |
| Weeks tracked | 92 |
| Tracking since | Jan 1, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CLOBETASOL PROPIONATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOBETASOL 0.05% OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for CLOBETASOL 0.05% OINTMENT, manufactured by Aurobindo Pharma Limited, is $0.1146 per GM (NDC 59651073260), effective Sep 30, 2026.
How has the price of CLOBETASOL 0.05% OINTMENT changed over time?
Over the history we have for it, the NADAC for CLOBETASOL 0.05% OINTMENT has declined 3.7%. It has been tracked across 92 weekly CMS publications since Jan 1, 2025.
What are the highest and lowest recorded NADAC prices for CLOBETASOL 0.05% OINTMENT?
Since Jan 1, 2025, the NADAC for CLOBETASOL 0.05% OINTMENT has ranged from a low of $0.1101 (Mar 18, 2026) to a high of $0.1627 (Jul 16, 2025), with a median of $0.1222 per GM.
Are there cheaper alternatives to CLOBETASOL 0.05% OINTMENT?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLOBETASOL 0.05% OINTMENT, is $0.1083 per GM — about 5% below CLOBETASOL 0.05% OINTMENT.
Who manufactures CLOBETASOL 0.05% OINTMENT?
CLOBETASOL 0.05% OINTMENT (NDC 59651073260) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.